SAN FRANCISCO, CA--(Marketwired - Apr 27, 2015) - Linkage Biosciences announced at the 29th European Immunogenetics and Histocompatibility Conference in Geneva, Switzerland a new distribution partnership with Voden Medical Instruments S.p.a. With a highly experienced leadership team, Voden Medical Instruments has a history of delivering the best quality and most advanced technologies to their customers. This new distribution partnership represents another step forward in providing LinkSeq HLA typing technology to customers around the world. "Voden Medical possesses a long standing record of excellent customer service and proven technical expertise, particularly in the area of HLA testing," said Zachary Antovich, CEO of Linkage Biosciences. "We are looking forward to partnering with Voden to provide LinkSeq HLA typing technology throughout Italy."